Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.83+0.01 (+0.55%)
Close on Nov 18, 2026Market cap $568.82MP/E –Yield 0.00%
Pacific Biosciences of California revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pacific Biosciences of California's revenue for the twelve months ending Jun 30, 2026 was $159.27M, up 2.0% year over year. For fiscal 2025 it was $160.01M, up 3.9% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is $200.52M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $160.01M | +3.9% |
| FY2024 | Dec 31, 2024 | $154.01M | -23.2% |
| FY2023 | Dec 31, 2023 | $200.52M | +56.3% |
| FY2022 | Dec 31, 2022 | $128.30M | -1.7% |
| FY2021 | Dec 31, 2021 | $130.51M | +65.4% |
| FY2020 | Dec 31, 2020 | $78.89M | -13.2% |
| FY2019 | Dec 31, 2019 | $90.89M | +15.6% |
| FY2018 | Dec 31, 2018 | $78.63M | -15.9% |
| FY2017 | Dec 31, 2017 | $93.47M | +3.0% |
| FY2016 | Dec 31, 2016 | $90.71M | -2.2% |
| FY2015 | Dec 31, 2015 | $92.78M | +53.1% |
| FY2014 | Dec 31, 2014 | $60.59M | +115.0% |
| FY2013 | Dec 31, 2013 | $28.18M | +8.5% |
| FY2012 | Dec 31, 2012 | $25.98M | -23.3% |
| FY2011 | Dec 31, 2011 | $33.86M | +1922.9% |
| FY2010 | Dec 31, 2010 | $1.67M | +1140.0% |
| FY2009 | Dec 31, 2009 | $135.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $39.01M | -1.9% |
| Q1 FY2026 | Mar 31, 2026 | $37.18M | +0.1% |
| Q4 FY2025 | Dec 31, 2025 | $44.65M | +13.8% |
| Q3 FY2025 | Sep 30, 2025 | $38.44M | -3.8% |
| Q2 FY2025 | Jun 30, 2025 | $39.77M | +10.4% |
| Q1 FY2025 | Mar 31, 2025 | $37.15M | -4.3% |
| Q4 FY2024 | Dec 31, 2024 | $39.22M | -32.8% |
| Q3 FY2024 | Sep 30, 2024 | $39.97M | -28.2% |
| Q2 FY2024 | Jun 30, 2024 | $36.01M | -24.3% |
| Q1 FY2024 | Mar 31, 2024 | $38.81M | -0.2% |
| Q4 FY2023 | Dec 31, 2023 | $58.36M | +113.3% |
| Q3 FY2023 | Sep 30, 2023 | $55.69M | +72.4% |
| Q2 FY2023 | Jun 30, 2023 | $47.57M | +34.1% |
| Q1 FY2023 | Mar 31, 2023 | $38.90M | +17.3% |
| Q4 FY2022 | Dec 31, 2022 | $27.35M | -24.1% |
| Q3 FY2022 | Sep 30, 2022 | $32.31M | -7.4% |
| Q2 FY2022 | Jun 30, 2022 | $35.47M | +15.9% |
| Q1 FY2022 | Mar 31, 2022 | $33.17M | +14.4% |
| Q4 FY2021 | Dec 31, 2021 | $36.02M | +32.7% |
| Q3 FY2021 | Sep 30, 2021 | $34.89M | +82.8% |
| Q2 FY2021 | Jun 30, 2021 | $30.61M | +60.4% |
| Q1 FY2021 | Mar 31, 2021 | $29.00M | +85.9% |
| Q4 FY2020 | Dec 31, 2020 | $27.14M | -2.8% |
| Q3 FY2020 | Sep 30, 2020 | $19.08M | -12.9% |
| Q2 FY2020 | Jun 30, 2020 | $19.08M | -22.5% |
| Q1 FY2020 | Mar 31, 2020 | $15.60M | -5.0% |
| Q4 FY2019 | Dec 31, 2019 | $27.93M | +43.0% |
| Q3 FY2019 | Sep 30, 2019 | $21.92M | +20.7% |
| Q2 FY2019 | Jun 30, 2019 | $24.62M | +14.1% |
| Q1 FY2019 | Mar 31, 2019 | $16.43M | -15.2% |
| Q4 FY2018 | Dec 31, 2018 | $19.53M | -21.7% |
| Q3 FY2018 | Sep 30, 2018 | $18.16M | -22.9% |
| Q2 FY2018 | Jun 30, 2018 | $21.58M | +7.5% |
| Q1 FY2018 | Mar 31, 2018 | $19.36M | -22.3% |
| Q4 FY2017 | Dec 31, 2017 | $24.94M | -3.1% |
| Q3 FY2017 | Sep 30, 2017 | $23.55M | -6.3% |
| Q2 FY2017 | Jun 30, 2017 | $20.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $24.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $25.72M | – |
| Q3 FY2016 | Sep 30, 2016 | $25.12M | – |
See a number that looks wrong?